<scp> <i>AMOTL1</i> </scp> ‐Associated Multiple Congenital Anomalies (Craniofaciocardiohepatic Syndrome, <scp>CFCHS</scp> ): A Novel Clinical Spectrum Including Craniofacial, Heart and Liver Abnormalities

We identified an AMOTL1 variant in a patient that adds evidence supporting the clinical and molecular overlap between AMOTL1-related disorders and other syndromes affecting craniofacial, cardiac, and hepatic development. As more cases are identified, we propose naming this entity as AMOTL1-associated multiple congenital anomalies or craniofaciocardiohepatic syndrome (CFCHS).

Authors

Institutions

Publication Details

Journal
Clinical Genetics
Published
2024-11-13
DOI
https://doi.org/10.1111/cge.14644
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

AMOTL1 ‐Associated Multiple Congenital Anomalies (Craniofaciocardiohepatic Syndrome, CFCHS ): A Novel Clinical Spectrum Including Craniofacial, Heart and Liver Abnormalities

Antonio Olveira, María D. Lledín, Karen Elise Heath, Pablo Lapunzina et al.
Clinical Genetics
RNA modifications and cancer
article

AMOTL1 ‐Associated Multiple Congenital Anomalies (Craniofaciocardiohepatic Syndrome, CFCHS ): A Novel Clinical Spectrum Including Craniofacial, Heart and Liver Abnormalities

Antonio Olveira, María D. Lledín, Karen Elise Heath, Pablo Lapunzina, Natalia Gallego, Alejandro Parra, Beatriz Morte, Julián Nevado, María Palomares‐Bralo, Ángel Carracedo, Emily Larrea, Jair Tenorio, Mario Cazalla, Elsa Lucas‐Castro, Emma Soengas
article en

Abstract

We identified an AMOTL1 variant in a patient that adds evidence supporting the clinical and molecular overlap between AMOTL1-related disorders and other syndromes affecting craniofacial, cardiac, and hepatic development. As more cases are identified, we propose naming this entity as AMOTL1-associated multiple congenital anomalies or craniofaciocardiohepatic syndrome (CFCHS).

Clinical GeneticsVol. 107(2)
Universidade de Santiago de Compostela (ES), Hospital Universitario La Paz (ES), Instituto de Salud Carlos III (ES), Centre for Biomedical Network Research on Rare Diseases (ES), Centro de Investigación Biomédica en Red (ES), Fundación Pública Galega de Medicina Xenómica (ES), Servicio Gallego de Salud (ES)
European Commission, Instituto de Salud Carlos III
Openalex Percentile: Top 82%
RNA modifications and cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.